ConductScience.org, home
A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.
API referenceFor AI assistants

Trial · NCT01638000

Adverse events66

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 66

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherDry mouthGastrointestinal disordersMirabegron 50 mg29936
otherDry mouthGastrointestinal disordersSolifenacin 5 mg54934
seriousPneumoniaInfections and infestationsMirabegron 50 mg1936
seriousPneumoniaInfections and infestationsSolifenacin 5 mg2934
seriousAppendicitisInfections and infestationsMirabegron 50 mg0936
seriousAppendicitisInfections and infestationsSolifenacin 5 mg1934
seriousPyelonephritisInfections and infestationsMirabegron 50 mg1936
seriousPyelonephritisInfections and infestationsSolifenacin 5 mg0934
seriousPyelonephritis acuteInfections and infestationsMirabegron 50 mg1936
seriousPyelonephritis acuteInfections and infestationsSolifenacin 5 mg0934
seriousUrosepsisInfections and infestationsMirabegron 50 mg0936
seriousUrosepsisInfections and infestationsSolifenacin 5 mg1934
seriousAbdominal pain upperGastrointestinal disordersMirabegron 50 mg1936
seriousAbdominal pain upperGastrointestinal disordersSolifenacin 5 mg1934
seriousInguinal herniaGastrointestinal disordersMirabegron 50 mg0936
seriousInguinal herniaGastrointestinal disordersSolifenacin 5 mg1934
seriousNauseaGastrointestinal disordersMirabegron 50 mg1936
seriousNauseaGastrointestinal disordersSolifenacin 5 mg0934
seriousHeadacheNervous system disordersMirabegron 50 mg1936
seriousHeadacheNervous system disordersSolifenacin 5 mg0934

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01638000/events

API referenceFor AI assistants